Talus Bio
Discovering drugs that target the DNA regulome
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment. Talus Bio is a Y Combinator company (Summer 2021). YC-listed status: Active.
- Website
- talus.bio
- Location
- Seattle, WA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Talus Bio — Drug discovery platform for previously undruggable genome regulators, measuring a drug's effect on the entire regulome in a single native-cell experiment. · Other
Links
- Y Combinator profileycombinator